MTPA announces long-term findings from post-marketing safety study of Radicava
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
It is a two dose vaccine to be administered intramuscularly at 28 days apart
The settlement and dismissal resolves all claims between the parties
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
Aurobindo Pharma Foundation endeavours to make a positive contribution to the underprivileged ommunities by supporting a wide range of socio-economic, educational, and health initiatives.
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers
Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
Indira IVF has established technological supremacy as the key differentiator, delivering industry leading success rate
TRIPS waiver for five years agreed in the recently concluded WTO will help countries manufacture COVID vaccines to deal with the pandemic
Subscribe To Our Newsletter & Stay Updated